LLLele Li

Lele Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lele Li has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of Oligopeptides from Pilose Antler Using Tandem Mass Tags Combined with Ultra-High-Performance Liquid Chromatography-Q-Orbitrap/Mass Spectrometry

    by Shengyu Ge, Muran Deng, Hailin Zhu, Lele Li

    Reports on oligopeptides derived from pilose antler remain scarce. There is an urgent need to establish a robust analytical method for detecting and characterizing these compounds. In this study, oligopeptide extracts from pilose antler were labeled with tandem mass tag (TMT) reagents and analyzed using ultra-high-performance liquid chromatography coupled with Q-Orbitrap/mass spectrometry (UHPLC-Q-Orbitrap/MS). Amino acid profiles and oligopeptide sequences were determined from accurate m/z values and tandem mass information. Twenty-six amino acids and 33 oligopeptides were identified in pilose antler extracts. The integrated TMT and UHPLC-Q-Orbitrap/MS approach enabled comprehensive analysis of oligopeptides and amino acids, establishing a foundation for holistic quality assessment of pilose antler oligopeptides.

  • Characterization of the Chemical Constituents in Shenyanshu Tablets by Ultra‐High‐Performance Liquid Chromatography Quadrupole Time‐of‐Flight Mass Spectrometry

    by Xing Wang, Jiao Guan, Chunfu Zhang, Yanwu Guan, Lihe Wang, Yan Yang, Shuangyu Li, Yang Liu, Lele Li, Yue Cui, et al.

    Shenyanshu tablets (SYST), a widely prescribed traditional Chinese patent medicine, which is clinically applied to treat chronic glomerulonephritis in China and other Asian countries. However, there is still no detailed report existing on its chemical composition at present, which hinders further investigation into its pharmacological activities and mechanism of action. To solve this difficult problem, an ultra‐high‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry method was established to separate and identify the chemical constituents of SYST. A total of 130 compounds were identified or characterized, among which 19 compounds were clearly confirmed by comparing their retention time and mass spectrometry data with those of reference standards. Based on the mass spectrometry data and relevant literature, the remaining compounds were preliminarily characterized. Results revealed that flavonoids, triterpenoid glycosides, organic acids, and alkaloids were the primary chemical components of SYST. The established analytical method has been proven to effectively characterize the chemical constituents of SYST and also provides important reference for clarifying the pharmacodynamic material basis and mechanism of action of SYST.

  • Identification of the Absorbed Constituents and Metabolites of Shenyanshu Tablets in Rat Plasma by Ultrahigh‐Performance Liquid Chromatography Coupled With Quadrupole Time‐of‐Flight Mass Spectrometry

    by Xing Wang, Shengyu Ge, ChunFu Zhang, Lihe Wang, Yan Yang, Shuangyu Li, Yang Liu, Lele Li, Renbo An, Jiao Guan, et al.

    Shenyanshu Tablets (SYST) is a traditional Chinese patent medicine composed of 10 kinds of Chinese herbal medicines, which has the functions of tonifying the kidney and strengthening the spleen, promoting diuresis and reducing swelling. It is well known that SYST can be used to treat chronic nephritis. However, due to the complexity of the formula, the pharmacological active components in SYST that can be absorbed into plasma have not been fully studied. In this study, an ultrahigh‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry (UHPLC‐Q‐TOF‐MS) method was first developed for separating and identifying the absorbed components and metabolites of SYST in rat plasma. A total of 33 compounds were identified or preliminarily characterized, including 18 prototype components and 15 metabolites. The results demonstrated that alkaloids, fatty acids, organic acids, and triterpenoid glycosides were the main prototype components, and triterpenoid glycoside–related metabolites, fatty acid–related metabolites, and flavonoid‐related metabolites were the major metabolites. These findings clarify the material basis of SYST in the treatment of chronic nephritis and provide references for further research and development of SYST.

  • Characterization of the Chemical Constituents in Modified Xihuang Pills by UHPLC‐Q‐TOF‐MS

    by Yan Yang, Jiao Guan, Yuhua Li, Wenjie Yu, Xing Wang, Shuangyu Li, Chunyu Yu, Lele Li, Heyun Zhu

    Modified Xihuang Pills (MXP), a widely used traditional Chinese patent medicine in China, has been clinically applied for treating inflammatory and infectious diseases. However, there are only a few reports on its chemical components at present, which hinders its further research, development, and application. In this study, an ultra‐high‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry (UHPLC‐Q‐TOF‐MS) method was developed firstly to investigate the major components in MXP. A total of 105 compounds were identified or characterized, among which 12 compounds were clearly confirmed by comparing the retention time and mass spectrometry data with those of reference standards. Based on the retention time, mass spectrometry data, and relevant literature information, the remaining 93 compounds were preliminarily characterized. Results showed that bile acids, bufadienolides, and terpenoids were the primary chemical components of MXP. The established analytical method has been proven to effectively characterize the chemical constituents of MXP and also provides an important reference for further in vivo pharmacokinetics and drug metabolism research on MXP.

  • Integrated UHPLC‐Q‐TOF‐MS Technology and Network Pharmacology Exploring the Pharmacodynamic Material Basis and Mechanism of Zhi‐Zi‐Hou‐Po Granule for Treatment of Depression–Anxiety Comorbidity

    by Yang Liu, Jiao Guan, Yan Yang, Xing Wang, Shuangyu Li, Shengyu Ge, Bo Feng, Lele Li, Lili Jin, Heyun Zhu

    Zhi‐Zi‐Hou‐Po Decoction (ZZHPD) is a classic traditional Chinese medicine (TCM) formula for treating depression and anxiety. Considering the disadvantages of decoction, our research group prepared ZZHPD into Zhi‐Zi‐Hou‐Po Granule (ZZHPG). However, the chemical composition and mechanism of ZZHPG for the treatment of depression–anxiety comorbidity remain unclear. In this study, the UHPLC‐Q‐TOF‐MS technology was applied to investigate the chemical constituents in ZZHPG, and network pharmacology was used to reveal the mechanism of ZZHPG. A total of 92 compounds were identified in ZZHPG. The network pharmacological analysis showed that 92 compounds regulated 132 pathways through 90 targets, among which 17 compounds maybe the material basis of ZZHPG for the treatment of depression–anxiety comorbidity, and osthole, obovatol, and naringenin may be the main pharmacodynamic components. Further research indicated that the mechanism of ZZHPG in treating depression–anxiety comorbidity may be related to the inhibition of nervous system disorders, activation of GABA receptors, anti‐inflammation, and reduction of oxidative stress. The molecular docking results showed that osthole, obovatol, and naringenin exhibited strong binding affinity with the core targets AKT1, ALB, TNF, EGFR, ESR1, and GSK3B. This research laid foundation for clinical application of ZZHPG and provided new ideas for the study of other TCM prescriptions.

  • Metabolite Identification of Huangqi Guizhi Wuwu Granules in Rat Urine and Feces Based on Ultra–High‐Performance Liquid Chromatography With Quadrupole Time‐of‐Flight Mass Spectrometry

    by Yang Liu, Yan Yang, Xing Wang, Shengyu Ge, Lele Li, Bo Feng, Lili Jin, Jiao Guan, Heyun Zhu

    Huangqi Guizhi Wuwu Decoction (HGWD), a famous Chinese medicine prescription, has been widely used in the treatment of diabetic peripheral neuropathy and scleroderma in China. Considering that the decoction was not easy to store and carry, our research group has converted HGWD into Huangqi Guizhi Wuwu Granules (HGWG) in the early stage. However, the in vivo metabolism profile of HGWG was still unclear. In this study, an ultra–high‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry (UHPLC‐Q‐TOF‐MS) method was established to identify prototypes and metabolites in urine and feces of rats after oral administration of HGWG. A total of 100 compounds were identified in urine and feces samples. In the urine samples, 28 prototype compounds and 41 related metabolites were identified. In the feces samples, 39 prototype compounds and 12 related metabolites were identified. Monoterpenoid glucosides, flavonoids, organic acids, gingerols, and terpenes were the main prototype compounds in both rat urine and feces. Flavonoid‐related metabolites, organic acid‐related metabolites, and gingerol‐related metabolites were the major metabolites in rat urine, and flavonoid‐related metabolites were the major metabolites in rat feces. This study can provide a theoretical basis for the drug metabolism and new drug development research of HGWG.


  • Characterization of the Chemical Constituents in Radix gentianae by Ultra-High Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry

    by Xu Pan, Jiao Guan, Yue Cui, Lele Li, Xiaoying Lin, Bo Feng, Heyun Zhu

    Radix gentianae (RG) is a traditional Chinese medicine used for the treatment of acute and chronic hepatitis in clinic. However, the chemical profile of RG is still unconfirmed, which hindered the progress of pharmacological study and clinical application. In this study, ultra-high performance liquid chromatography together with quadrupole time-of-flight mass spectrometry techniques were employed to separate and characterize the chemical constituents in RG. Under the optimized conditions, a total of 60 compounds were rapidly identified or tentatively characterized. Results indicated that iridoid glucosides, flavonoids, organic acids, amino acids, saccharides and nucleosides were major constituents in RG. It is concluded the established method can help to clarify the substance basis and provide useful information for ascertaining the bioactive constituents and action mechanism of RG.


  • Open Access

    Chemical Profiling, Quantitation, and Bioactivities of Ginseng Residue

    by Shengyu Ge, Jinlong Liu, Yang Liu, Jiaqi Song, Hongfeng Wu, Lele Li, Heyun Zhu, Bo Feng

    Ginseng residue is a by-product stemming from the commercial extraction of ginsenosides. To assess the disparities between ginseng residue and ginseng tablet, we employed the ultra-high-performance liquid chromatography–quadrupole time-of-flight/mass spectrometry (UPLC-Q-TOF/MS) technique for sample analysis. The analyses revealed the presence of 39 compounds in both ginseng residue and ginseng tablets. Subsequently, the contents of total ginsenosides and total ginseng polysaccharides in the ginseng residue and ginseng tablet were determined. The results indicate that while only a small fraction of ginsenosides remained in the ginseng residue, a significant amount of polysaccharides was retained. Furthermore, our evaluation encompassed the antioxidant activities of both ginseng residue and ginseng tablets. Notably, ginseng residue exhibited robust antioxidant effects, thereby showcasing its potential for recycling as a functional food raw material.


  • Identification of the absorbed constituents and metabolites of Huangqi Guizhi Wuwu decoction by ultrahigh‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry

    by Zhuoyu Fan, Lele Li, Yue Cui, Xinmiao Tang, Guanghai Shen, Bo Feng, Jiao Guan, Heyun Zhu

    Huangqi Guizhi Wuwu decoction (HGWWD) is a widely used traditional Chinese medicine (TCM) preparation for the treatment of ischemic stroke and diabetes peripheral neuropathy. However, the material basis for the efficacy of HGWWD remains unclear. In this study, a rapid, sensitive and selective ultrahigh‐performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry (UHPLC–Q‐TOF–MS) method was developed to separate and identify the absorbed components and metabolites of HGWWD in rat plasma after oral administration for the first time. By comparing the retention time, high‐resolution mass spectrometry primary and secondary mass spectrometry data of blank plasma and drug‐containing plasma, a total of 42 constituents, including 24 prototype compounds and 18 metabolites, were identified or tentatively characterized. The results indicated that monoterpenes, flavonoids, organic acids, amino acids, gingerols and alkaloids were main prototype compounds in rat plasma, and flavonoid‐related metabolites, organic acid‐related metabolites and gingerol‐related metabolites were major metabolites. It is concluded the developed UHPLC–Q‐TOF–MS method with high sensitivity and resolution is suitable for identifying and characterizing the absorbed components and metabolites of HGWWD, and the results will provide important data for further study on the relationship between the chemical constituents and pharmacological activities of HGWWD.


  • Characterization of chemical constituents in Huangqi Guizhi Wuwu decoction using ultra‐high performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry

    by Zhuoyu Fan, Jiao Guan, Lele Li, Yue Cui, Xinmiao Tang, Xiaoying Lin, Guanghai Shen, Bo Feng, Heyun Zhu

    Huangqi Guizhi Wuwu decoction (HGWWD) is a classic traditional Chinese medicine prescription for the treatment of ischemic stroke, etc. However, the material basis of its efficacy remains unclear, seriously affecting drug development and clinical applications. In the present study, an ultra‐high performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry method was developed to separate and identify the chemical components of HGWWD. A total of 81 compounds were identified and tentatively characterized. Eight compounds were accurately identified by comparing the retention time and mass spectrometry data with those of reference substances, the remaining compounds were characterized by comparing the mass spectrometry data and reference information. Based on the results of compound attribution, 35 compounds were from Astragali Radix, six compounds were from Cinnamomi Ramulus, 23 compounds were from Paeoniae Radix Alba, eight compounds were from Zingiberis Rhizoma Recens and nine compounds were from Jujubae Fructus. The results showed that monoterpenoids, flavonoids, organic acids, triterpenes, amino acids, gingerols, alkaloids, and glycosides were the main chemical components of HGWWD. This analytical method is suitable for characterizing the chemical constituents of HGWWD, and the results provide important information for elucidating its pharmacodynamic material basis and mechanism of action.